American regulators are reportedly set to authorize use of Pfizer’s COVID-19 vaccine in children between 12 and 15 years old.
Both the New York Times and CNN report clearance from the Food and Drug Administration could come by early next week.
Health Canada has told 680 NEWS the pharmaceutical giant applied for authorization for its vaccine for that age group on April 16.
“The Department is currently reviewing the submission and will only issue a decision following a thorough scientific review of the vaccine’s safety and efficacy in this younger age group,” Health Canada said in a statement.
At the end of March, the company announced results from its clinical trial involving more than 2,200 adolescents, showing the vaccine was 100 per cent effective in preventing COVID in 12-to-15-year-olds.
Pfizer’s vaccine is currently authorized in both Canada and the U.S. in people 16 and older.
In the GTA, Halton Region is expanding eligibility to residents 16 and older who cannot work from home starting May 10, depending on supply.
Health Canada tells me it has received a submission from Pfizer to expand the use of its COVID-19 vaccine on children aged 12-15. This submission is under review. Pfizer is currently authorized for use in people 16 years of age and older. @680NEWS @CityNews https://t.co/LJFIOqqlWo
— Caryn Ceolin (@carynceolin) May 3, 2021